Marc Stefanski, TFS Financial CEO, sells $172,800 in company stock By Investing.com
Aehr Test Systems director Scott sells $2.63m in stock By Investing.com

Geoffrey G. Scott, a director at Aehr Test Systems (), recently reported transactions involving the company’s common stock. On August 12, 2026, Scott sold 20,000 shares of Aehr Test Systems common stock at a price of $131.506 per share, totaling $2,630,120. The sale comes as the stock trades near its 52-week high of $133.35, following a remarkable 554% return over the past year. According to InvestingPro analysis, the stock currently appears overvalued relative to its Fair Value—a metric available to subscribers alongside comprehensive analysis for over 1,400 US equities on the most overvalued stocks list.
On the same date, Scott also disposed of 6,731 shares of common stock through a donation. These shares were gifted to the Scott Family Gift Fund.
Following these transactions, Scott’s beneficial ownership in Aehr Test Systems includes 23,955 shares held indirectly by a trust, 10,000 shares held indirectly by a spouse, and 51,648 shares held directly. The direct holdings include shares subject to unvested restricted stock units.
In other recent news, Aehr Test Systems reported fiscal fourth-quarter earnings that surpassed Wall Street expectations, with adjusted earnings of $0.11 per share on revenue of $18.8 million. Analysts had anticipated a loss of $0.01 per share on revenue of $17.92 million. The company also announced record quarterly bookings of $60.7 million, pushing its backlog to over $100 million. Additionally, Aehr Test Systems received a $22 million follow-on production order from its lead wafer-level AI processor customer for burn-in systems, which will be shipped over the next six months to a manufacturing partner in Taiwan. The company also secured a follow-on production order for a fully automated FOX-XP multi-wafer production burn-in system from its lead silicon photonics customer, scheduled for delivery in the first half of 2027. Furthermore, Freedom Broker upgraded Aehr Test Systems to a Buy rating from Hold, raising its price target to $110 from $90. This upgrade follows the company’s fiscal 2026 results and its guidance for fiscal 2027 revenue of $130 million to $150 million.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
